Mercer Global Advisors
IRON icon

Mercer Global Advisors’s Disc Medicine IRON Stock Holding History

Mercer Global Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Buy
+1,720
New +$118K ﹤0.01% 3661

Other funds holding IRON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mercer Global Advisors's IRON Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Disc Medicine (IRON) in Q2 2026: 1,720 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #3661 among its holdings.

197 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Mercer Global Advisors held 1,720 shares of Disc Medicine worth $126K as of Q2 2026.
  • Disc Medicine was a new Mercer Global Advisors position in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3661 holding.
  • 197 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.